Internal Medicine, Nephrology · North Kansas City, MO
NPI
1982897682
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2790 Clay Edwards Dr, Suite 410
North Kansas City, MO, 64116
Phone (816) 474-9353
Groups this clinician bills Medicare through
Medicare paid, 2024
$298K
3,194 services
Medicare patients, 2024
720
Average age 74
Drug cost, 2024
$316K
1,748 prescriptions
Company payments, 2025
$1,388
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suleiman Daifallah was code 99232 (hospital e&m - subsequent), 958 times for 282 patients. In total Suleiman Daifallah billed 3,194 services in 22 codes, and Medicare paid $298K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 958 | 282 | $59.30 | $57K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 370 | 307 | $11.98 | $4,432 |
| 90960 ESRD Related Services (not dialysis) | Office | 369 | 60 | $269.43 | $99K |
| 99214 Office E&M - Established | Office | 352 | 288 | $57.67 | $20K |
| 90970 ESRD Related Services (not dialysis) | Office | 306 | 18 | $7.27 | $2,225 |
| 99222 Hospital E&M - Initial | Facility | 194 | 165 | $97.70 | $19K |
| 90966 ESRD Related Services (not dialysis) | Office | 159 | 24 | $220.79 | $35K |
| 99291 Critical Care E&M | Facility | 138 | 73 | $158.18 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 81 | 56 | $91.25 | $7,392 |
| 90935 Hemodialysis | Facility | 65 | 39 | $54.77 | $3,560 |
| 99204 Office E&M - New | Office | 47 | 47 | $109.73 | $5,157 |
| 90961 ESRD Related Services (not dialysis) | Office | 45 | 27 | $228.70 | $10K |
| 99223 Hospital E&M - Initial | Facility | 41 | 39 | $130.98 | $5,370 |
By year: 2022 $232K for 2,219 services; 2023 $288K for 2,957 services; 2024 $298K for 3,194 services.
Medicare prescription drug claims, 2024
In 2024, the drug Suleiman Daifallah prescribed most often to Medicare patients was Allopurinol, with 241 prescriptions and refills. In total Suleiman Daifallah wrote 1,748 Medicare prescriptions that cost $316K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 241 | 590 | 66 | $1,847 |
| Furosemide Generic | 171 | 365 | 51 | $650 |
| Losartan Potassium Generic | 148 | 360 | 43 | $972 |
| Amlodipine Besylate Generic | 130 | 268 | 32 | $735 |
| Lisinopril Generic | 105 | 241 | 29 | $593 |
| Calcitriol Generic | 81 | 171 | 22 | $1,572 |
| Tamsulosin Hcl Generic | 70 | 142 | 23 | $538 |
| Calcium Acetate Generic | 56 | 90 | 19 | $3,597 |
| Potassium Chloride Generic | 54 | 117 | 19 | $561 |
| Carvedilol Generic | 50 | 106 | 13 | $315 |
| Nifedipine Er Nifedipine | 48 | 88 | 12 | $939 |
| Hydrochlorothiazide Generic | 45 | 100 | Under 11 | $73.85 |
| Clinisol Parenteral Amino Acid 15% No.5 | 39 | 39 | Under 11 | $15K |
| Hydralazine Hcl Generic | 36 | 78 | 14 | $635 |
| Sevelamer Carbonate Generic | 28 | 44 | 13 | $6,985 |
Brand drugs: 201 claims; generic drugs: 1,547 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suleiman Daifallah $1,388 ($1,388 in general payments such as food, travel and fees) from 17 companies. The largest payer was Calliditas Therapeutics US Inc. with $344.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 12 | $344 |
| Amgen Inc. AMGN | 10 | $203 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $147 |
| Novo Nordisk Inc NVO | 3 | $66.9 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $59.85 |
| Fresenius USA Marketing, Inc. | 3 | $57.87 |
| GlaxoSmithKline, LLC. GSK | 3 | $57.76 |
| Mallinckrodt Hospital Products Inc. | 2 | $57.25 |
| Travere Therapeutics, Inc. TVTX | 5 | $40.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.